(SNDA) Sonida Senior Living - Overview
Sector: Healthcare | Industry: Medical Care Facilities | Exchange: NYSE (USA) | Market Cap: 1.500m USD | Total Return: 43% in 12m
Avg Trading Vol: 20.9M USD
Peers RS (IBD): 83.9
EPS Trend: 13.8%
Qual. Beats: 1
Rev. Trend: 97.9%
Qual. Beats: 0
Sonida Senior Living, Inc. (SNDA) operates senior housing communities across the United States. The company provides a range of services tailored to the needs of older adults.
Its offerings include independent living, which focuses on daily meals, transportation, and social activities. This segment caters to seniors who require minimal assistance. The senior living sector often sees demand driven by an aging population.
Assisted living services provide personal care for activities such as bathing, dressing, and medication management. This model offers a higher level of support than independent living. Many companies in this industry also offer specialized memory care for residents with dementia.
Sonida also facilitates access to third-party home care services, including medical and rehabilitation therapies. Respite care and temporary care programs are also available. Understanding the nuances of these service lines is crucial for a complete financial picture; further research on platforms like ValueRay can provide deeper insights.
- Occupancy rates in senior living facilities directly impact revenue
- Labor costs for care staff pressure operating margins
- Government healthcare policy changes affect reimbursement rates
- Interest rate hikes increase debt servicing expenses
| Net Income: -70.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 2.15 > 1.0 |
| NWC/Revenue: -7.15% < 20% (prev -3.79%; Δ -3.36% < -1%) |
| CFO/TA 0.03 > 3% & CFO 24.4m > Net Income -70.8m |
| Net Debt (678.7m) to EBITDA (23.2m): 29.20 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.1m) vs 12m ago 0.32% < -2% |
| Gross Margin: -7.97% > 18% (prev 0.89%; Δ -885.9% > 0.5%) |
| Asset Turnover: 45.19% > 50% (prev 36.15%; Δ 9.05% > 0%) |
| Interest Coverage Ratio: -0.87 > 6 (EBITDA TTM 23.2m / Interest Expense TTM 38.6m) |
| A: -0.03 (Total Current Assets 77.9m - Total Current Liabilities 105.1m) / Total Assets 844.8m |
| B: -0.58 (Retained Earnings -491.0m / Total Assets 844.8m) |
| C: -0.04 (EBIT TTM -33.5m / Avg Total Assets 843.4m) |
| D: -0.62 (Book Value of Equity -490.8m / Total Liabilities 788.6m) |
| Altman-Z'' Score: -3.03 = D |
| DSRI: 0.78 (Receivables 18.6m/19.0m, Revenue 381.1m/304.3m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.81 (AQ_t 0.04 / AQ_t-1 0.05) |
| SGI: 1.25 (Revenue 381.1m / 304.3m) |
| TATA: -0.11 (NI -70.8m - CFO 24.4m) / TA 844.8m) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
Over the past week, the price has changed by +1.67%, over one month by -11.79%, over three months by +0.69% and over the past year by +42.96%.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Wallstreet Target Price | 34 | 5.4% |
| Analysts Target Price | 34 | 5.4% |
P/S = 4.4586
P/B = 22.1097
P/EG = 2.0444
Revenue TTM = 381.1m USD
EBIT TTM = -33.5m USD
EBITDA TTM = 23.2m USD
Long Term Debt = 682.5m USD (from longTermDebt, last quarter)
Short Term Debt = 7.29m USD (from shortTermDebt, last quarter)
Debt = 689.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.18b USD (1.50b + Debt 689.7m - CCE 11.0m)
Interest Coverage Ratio = -0.87 (Ebit TTM -33.5m / Interest Expense TTM 38.6m)
EV/FCF = -244.2x (Enterprise Value 2.18b / FCF TTM -8.92m)
FCF Yield = -0.41% (FCF TTM -8.92m / Enterprise Value 2.18b)
FCF Margin = -2.34% (FCF TTM -8.92m / Revenue TTM 381.1m)
Net Margin = -18.57% (Net Income TTM -70.8m / Revenue TTM 381.1m)
Gross Margin = -7.97% ((Revenue TTM 381.1m - Cost of Revenue TTM 411.5m) / Revenue TTM)
Gross Margin QoQ = -156.5% (prev 21.01%)
Tobins Q-Ratio = 2.58 (Enterprise Value 2.18b / Total Assets 844.8m)
Interest Expense / Debt = 1.45% (Interest Expense 10.0m / Debt 689.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -26.5m (EBIT -33.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.74 (Total Current Assets 77.9m / Total Current Liabilities 105.1m)
Debt / Equity = 13.46 (Debt 689.7m / totalStockholderEquity, last quarter 51.2m)
Debt / EBITDA = 29.20 (Net Debt 678.7m / EBITDA 23.2m)
Debt / FCF = -76.09 (negative FCF - burning cash) (Net Debt 678.7m / FCF TTM -8.92m)
Total Stockholder Equity = 87.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.39% (Net Income -70.8m / Total Assets 844.8m)
RoE = -80.84% (Net Income TTM -70.8m / Total Stockholder Equity 87.6m)
RoCE = -4.35% (EBIT -33.5m / Capital Employed (Equity 87.6m + L.T.Debt 682.5m))
RoIC = -3.72% (negative operating profit) (NOPAT -26.5m / Invested Capital 712.0m)
WACC = 6.25% (E(1.50b)/V(2.19b) * Re(8.60%) + D(689.7m)/V(2.19b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 8.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 57.16%
[DCF] Fair Price = unknown (Cash Flow -8.92m)
EPS Correlation: 13.76 | EPS CAGR: 17.49% | SUE: 2.44 | # QB: 1
Revenue Correlation: 97.90 | Revenue CAGR: 18.63% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-1.94 | Chg7d=-1.940 | Chg30d=-1.940 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=-5.09 | Chg7d=-5.090 | Chg30d=-5.090 | Revisions Net=+0 | Growth EPS=-20.6% | Growth Revenue=+45.6%
EPS next Year (2027-12-31): EPS=-0.94 | Chg7d=-0.940 | Chg30d=-0.940 | Revisions Net=+0 | Growth EPS=+81.5% | Growth Revenue=+11.1%